MTHFD2L
Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase 2, mitochondrial
Also known as: MGC72244, MTD2L_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9H903
- Gene
- MTHFD2L
- Ensembl
- ENSG00000163738
- Chromosome
- 4
- Canonical length
- 347 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins
OverviewNCBI Gene
Predicted to enable methenyltetrahydrofolate cyclohydrolase activity; methylenetetrahydrofolate dehydrogenase (NAD+) activity; and methylenetetrahydrofolate dehydrogenase (NADP+) activity. Predicted to be involved in tetrahydrofolate interconversion. Located in mitochondrion. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
347 residues, UniProt reviewed canonical sequence.
>Q9H903|MTHFD2L
1 MTVPVRGFSL LRGRLGRAPA LGRSTAPSVR APGEPGSAFR GFRSSGVRHE AIIISGTEMA
61 KHIQKEIQRG VESWVSLGNR RPHLSIILVG DNPASHTYVR NKIRAASAVG ICSELILKPK
121 DVSQEELLDV TDQLNMDPRV SGILVQLPLP DHVDERTICN GIAPEKDVDG FHIINIGRLC
181 LDQHSLIPAT ASAVWEIIKR TGIQTFGKNV VVAGRSKNVG MPIAMLLHTD GEHERPGGDA
241 TVTIAHRYTP KEQLKIHTQL ADIIIVAAGI PKLITSDMVK EGAAVIDVGI NYVHDPVTGK
301 TKLVGDVDFE AVKKKAGFIT PVPGGVGPMT VAMLLKNTLL AAKKIIYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MTHFD2L can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 3.5 nTPM
Expression across tissuesHPA
Tissue
- liver: 3.5 nTPM
- heart muscle: 3.4 nTPM
- epididymis: 3.1 nTPM
- cerebral cortex: 1.5 nTPM
- hypothalamus: 1.5 nTPM
- spinal cord: 1.5 nTPM
Single-cell type
- breast lactating cells: 635 nCPM
- alveolar cells type 2: 300 nCPM
- epididymal principal cells: 295 nCPM
- hepatocytes: 248 nCPM
- transitional alveolar cells: 200 nCPM
- hematopoietic stem cells: 185 nCPM
Immune cell
- plasmacytoid DC: 0.4 nTPM
- memory B-cell: 0.3 nTPM
- myeloid DC: 0.3 nTPM
- T-reg: 0.3 nTPM
- total PBMC: 0.3 nTPM
- classical monocyte: 0.2 nTPM
Brain region
- white matter: 3.1 nTPM
- hypothalamus: 2.3 nTPM
- cerebral cortex: 2 nTPM
- midbrain: 2 nTPM
- pons: 2 nTPM
- medulla oblongata: 1.9 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.16
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.17
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- folic acid metabolic process
- methionine biosynthetic process
- purine nucleotide biosynthetic process
- tetrahydrofolate interconversion
- 10-formyltetrahydrofolate metabolic process
Molecular functions
- methenyltetrahydrofolate cyclohydrolase activity
- methylenetetrahydrofolate dehydrogenase (NAD+) activity
- methylenetetrahydrofolate dehydrogenase (NADP+) activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Tetrahydrofolate dehydrogenase/cyclohydrolase
- Tetrahydrofolate dehydrogenase/cyclohydrolase, catalytic domain
- Tetrahydrofolate dehydrogenase/cyclohydrolase, NAD(P)-binding domain
- Tetrahydrofolate dehydrogenase/cyclohydrolase, conserved site
- NAD(P)-binding domain superfamily
- Aminoacid dehydrogenase-like, N-terminal domain superfamily
- Tetrahydrofolate dehydrogenase/cyclohydrolase, catalytic domain
- Tetrahydrofolate dehydrogenase/cyclohydrolase, NAD(P)-binding domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MTHFD2L as an antibody target. Whether an autoantibody or antibody against MTHFD2L could matter depends on whether native MTHFD2L is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MTHFD2L is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MTHFD2L as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...